Skin Chips: An Innovative Paradigm for Precise Efficacy Research of Cosmetics

Cooperation Agreement Signed

Recently, Suzhou Luohua Biotechnology Co., Ltd. (“LUOHUA” for short) and Wuhan CASOV Green Biotech Co., Ltd. ("CASOV" for short) officially signed a cooperation agreement to jointly carry out R & D and application cooperation of skin chip technology in the cosmetics field. This cooperation will focus on the development and application of skin chip models, aiming to provide more precise and efficient solutions for cosmetic efficacy evaluation, safety testing, and personalized product R & D, and promote the cosmetics industry to a new stage of technology - driven and intelligent development.

Skin Chip Technology: A New Engine for Cosmetics R & D

As a cutting - edge biotechnological platform, skin chips can highly mimic the physiological structure and functions of human skin, offering brand - new ideas and tools for cosmetics research and development. Relying on its profound technical accumulation in the field of organoid chips, LUOHUA has successfully developed a variety of skin chip models, including epidermal models, full - thickness skin models, and vascularized skin models, which are widely used in the evaluation of cosmetic efficacy, safety testing, and the development of personalized products.

Dr. Miao Chunguang, the founder of LUOHUA, stated, "The core advantages of skin chip technology lie in its high physiological relevance and precision. It can simulate the micro - environment of real skin in vitro, providing a more reliable and efficient testing platform for cosmetics R & D. This cooperation with CASOV will accelerate the practical application of skin chip technology in the cosmetics industry, helping CASOV achieve a qualitative leap in product development and market competitiveness.

In-depth Cooperation to Jointly Promote Industry Innovation

According to the agreement, LUOHUA will provide customized skin chip model development services for CASOV, covering the whole process of technical support from basic model construction to efficacy evaluation and safety testing. CASOV will utilize the skin chip platform of LUOHUA to conduct precise efficacy tests on cosmetic raw materials such as whitening, sun protection, moisturizing, and repairing, and explore new paths for the development of personalized products.

Dr. Liu Yang, the head of R & D at CASOV, said, "The emergence of skin chip technology has brought new hope to the industry. We look forward to accelerating the product R & D process, improving product efficacy and safety, and meeting consumers' demands for personalized products through our cooperation with LUOHUA and by leveraging this innovative platform."

Technology Empowerment: Opening a New Era of Cosmetics R & D

LUOHUA has demonstrated strong technical strength and innovation capabilities in the development and application of skin chip technology. The company has not only achieved remarkable results in the construction of skin chip models but also covered the entire chain from basic research to commercial application through its intelligent and high-throughput technology platform. In this cooperation, LUOHUA will provide all-round technical support to CASOV, from model construction to data analysis, helping CASOV to reduce costs, increase efficiency, and achieve technological innovation in the research and development of cosmetic raw materials.

The parent company of CASOV, CABIO Biotech (Wuhan) Co., Ltd., is the first company in Hubei Province listed on the Science and Technology Innovation Board. Relying on the strong background of its parent company, CASOV uses core technical means such as AI computing, synthetic biology, microbial fermentation, co-delivery technology of encapsulation carriers, and omics mechanism technology to provide customers with high-quality application solutions for cosmetic raw materials, encapsulation carrier technology, and mechanism research of active ingredients.

As a leading synthetic biology enterprise in China, CASOV provides high-quality nutrient products and innovative solutions for customers in the global nutrition and health field. This cooperation with LUOHUA marks a significant transformation in its R & D model. The Marketing Director of CASOV said, "With consumers' increasing demands for the efficacy and safety of cosmetics, the traditional R & D model can hardly meet the market needs. The emergence of skin chip technology has brought new opportunities to the industry. We hope that through our cooperation with LUOHUA and by leveraging this innovative platform, we can enhance product competitiveness and lead the development trend of the industry.

Forward-looking Layout: Jointly Exploring a New Future for the Industry

The cooperation between LUOHUA and CASOV is not only a powerful combination of the two parties in terms of technology and resources but also an important milestone in the application of skin chip technology in the cosmetics field. As the cooperation deepens continuously, the two parties will jointly explore more application scenarios of skin chip technology in cosmetics research and development, providing new solutions for the global cosmetics industry.

Dr. Miao Chunguang, the founder of LUOHUA, emphasized, "The future of skin chip technology lies in its deep integration with cosmetics research and development. Through our cooperation with CASOV, we hope to further explore the application scenarios of this technology in the cosmetics field and provide new research and development ideas and solutions for the global cosmetics industry. In the future, LUOHUA will continue to increase investment in research and development, improve its technical level, and strive to become a leading global provider of organoid chip technology."

The cooperation between LUOHUA and CASOV marks that the application of skin chip technology in the cosmetics industry has entered a new stage. With the continuous deepening of the cooperation between the two parties, it will bring more innovative achievements to the cosmetics industry and provide consumers with safer, more effective, and more personalized cosmetic products. 

About CASOV

Wuhan CASOV Green Biotech Co., Ltd. was established in December 2010 and was recognized as a National High-tech Enterprise in October 2014. The company has strong technical strength and serves as the operation and management entity of the Biotechnology Engineering Center of Hubei Industrial Technology Innovation and Incubation Center, Chinese Academy of Sciences. It also collaborates with the senior research team of Hefei Institutes of Physical Science, Chinese Academy of Sciences for joint research and continuous innovation. With core technologies such as AI computing, multi-omics joint analysis technology, synthetic biology, microbial fermentation, and encapsulation carrier co-delivery technology, the company provides customers with high-quality application solutions for cosmetics raw materials, encapsulation carrier technology, and mechanism research of active ingredients. 

The parent company of Wuhan CASOV Green Biotech Co., Ltd., is listed on the STAR Market (STAR Market IPO), with the stock code: 688089, and it is the first company in Hubei Province to be listed on the STAR Market.